SEC Filings for Ligand Pharmaceuticals Incorporated (LGND)

$ 108.90   0.10 (+0.09%) Volume: 356.06k 4:00 PM EST Nov 11, 2019
Filing Type:
Form TypeForm DescriptionPagesDateView
4Statement of changes in beneficial ownership of securities106/12/2019
4Statement of changes in beneficial ownership of securities106/12/2019
4Statement of changes in beneficial ownership of securities106/10/2019
8-KCurrent report pursuant to Section 13 or 15(d)206/10/2019
4Statement of changes in beneficial ownership of securities106/07/2019
4Statement of changes in beneficial ownership of securities106/07/2019
4Statement of changes in beneficial ownership of securities106/07/2019
4Statement of changes in beneficial ownership of securities106/07/2019
4Statement of changes in beneficial ownership of securities106/07/2019
4Statement of changes in beneficial ownership of securities106/07/2019
DEFA14AAdditional proxy soliciting materials - definitive206/04/2019
8-KCurrent report pursuant to Section 13 or 15(d)206/03/2019
4Statement of changes in beneficial ownership of securities105/31/2019
4Statement of changes in beneficial ownership of securities105/31/2019
8-KCurrent report pursuant to Section 13 or 15(d)205/24/2019
123456789101112131415